Literature DB >> 6451172

Animal models of diabetes.

J P Mordes, A A Rossini.   

Abstract

Spontaneous diabetes is a common occurrence in many animal species. In addition, animals can be rendered diabetic by a wide variety of experimental procedures. Diabetic animals may be regarded as models of the disease in man. However, such animals display a wide diversity of pathophysiology, and, in fact, no animal syndrome corresponds precisely to any type of diabetes in human subjects. The most common diabetes syndromes in animals occur in the context of obesity, hyperinsulinemia and insulin resistance. Many such syndromes remit spontaneously. Dietary restriction and weight reduction effectively reverse some of these syndromes, but in other cases only partial correction of the syndrome occurs. Diabetes in lean animals is less common. The diabetes of lean animals is more frequently characterized by hypoinsulinemia, ketosis and insulin dependence than is the case with obese animals. Diabetes may be produced experimentally by means of surgery, viral infection or the administration of various hormones and chemical agents. Both the spontaneous and experimental animal models have been used effectively to study the etiologies, complications, treatments and prevention of diabetes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6451172     DOI: 10.1016/0002-9343(81)90772-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  21 in total

1.  Effect of streptozotocin-induced diabetes on performance on a progressive ratio schedule.

Authors:  Lourdes Valencia-Torres; C M Bradshaw; Arturo Bouzas; Enrique Hong; Vladimir Orduña
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

Review 2.  Pancreatic beta-cells: from generation to regeneration.

Authors:  Patrick Collombat; Xiaobo Xu; Harry Heimberg; Ahmed Mansouri
Journal:  Semin Cell Dev Biol       Date:  2010-08-03       Impact factor: 7.727

3.  Topical application of laminin-332 to diabetic mouse wounds.

Authors:  Stephen R Sullivan; Robert A Underwood; Randall O Sigle; Yuko Fukano; Lara A Muffley; Marcia L Usui; Nicole S Gibran; Marcos A Antezana; William G Carter; John E Olerud
Journal:  J Dermatol Sci       Date:  2007-08-24       Impact factor: 4.563

4.  PDGF and FGF stimulate wound healing in the genetically diabetic mouse.

Authors:  D G Greenhalgh; K H Sprugel; M J Murray; R Ross
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

5.  Cystometric changes in the early phase of streptozotocin-induced diabetes in rats: evidence for sensory changes not correlated to diabetic neuropathy.

Authors:  P Santicioli; R Gamse; C A Maggi; A Meli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

6.  Insulin and glucocorticoid dependence of hepatic gamma-glutamylcysteine synthetase and glutathione synthesis in the rat. Studies in cultured hepatocytes and in vivo.

Authors:  S C Lu; J L Ge; J Kuhlenkamp; N Kaplowitz
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

7.  Early molecular changes associated with streptozotocin-induced diabetic bladder hypertrophy in the rat.

Authors:  H P Koo; R P Santarosa; R Buttyan; R Shabsigh; C A Olsson; S A Kaplan
Journal:  Urol Res       Date:  1993

8.  Interactions of hearing loss and diabetes mellitus in the middle age CBA/CaJ mouse model of presbycusis.

Authors:  Olga N Vasilyeva; Susan T Frisina; Xiaoxia Zhu; Joseph P Walton; Robert D Frisina
Journal:  Hear Res       Date:  2009-03       Impact factor: 3.208

9.  Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.

Authors:  A C Kappelle; B Bravenboer; T van Buren; J Traber; D W Erkelens; W H Gispen
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

10.  Modulation of a glycoprotein recognition system on rat hepatic endothelial cells by glucose and diabetes mellitus.

Authors:  J A Summerfield; J Vergalla; E A Jones
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.